Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

BACKGROUND: We aimed to compare overall survival after standard-dose versus high-dose conformal radiotherapy with concurrent chemotherapy and the addition of cetuximab to concurrent chemoradiation for patients with inoperable stage III non-small-cell lung cancer. METHODS: In this open-label randomis...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Lancet Oncol
मुख्य लेखकों: Bradley, Jeffrey D, Paulus, Rebecca, Komaki, Ritsuko, Masters, Gregory, Blumenschein, George, Schild, Steven, Bogart, Jeffrey, Hu, Chen, Forster, Kenneth, Magliocco, Anthony, Kavadi, Vivek, Garces, Yolanda I, Narayan, Samir, Iyengar, Puneeth, Robinson, Cliff, Wynn, Raymond B, Koprowski, Christopher, Meng, Joanne, Beitler, Jonathan, Gaur, Rakesh, Curran, Walter, Choy, Hak
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2015
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4419359/
https://ncbi.nlm.nih.gov/pubmed/25601342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(14)71207-0
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन